1. Africa's victory, Africa's sorrow

2. A tough challenge

3.Multiple proteins

4. Immune-system helper

5. Making sense of vaccines

BIBLIOGRAPHY
Paper:
Children of the Apocalypse, The, Gareth Woods-Jack, The Independent (London), Nov. 26, 2000, p. 18ff.

Control of Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine, Rama Rao Amara et al, Science, Apr. 6, 2001, pp. 69-74.

Despite Legal Victory, South Africa Hesitates on AIDS Drugs, Rachel Swarns, The New York Times, Apr. 21, 2001, p. A4.

Free Aids Care Brings Hope to Botswana, Rachel Swarns, The New York Times, May 8, 2001.

HIV Inhibitor Blocks Virus From Cell, Laura Helmuth, Science, 12 Jan. 2001, p. 229.

Lifting the Curtain on the Real Costs of Making AIDS Drugs, Melody Peterson, The New York Times, Apr. 24, 2001 p. C1.

Merck Reemerges With a Bold AIDS Vaccine Effort, Jon Cohen, Science, 6 April 2001, pp. 24-5.

Protein Design of an HIV-1 Entry Inhibitor, Michael Root et al, Science, Feb. 2, 2001, pp. 884-8.

Shots in the Dark (history of AIDS vaccine research), Jon Cohen, W.W. Norton and Company, 2001.

T-Cell Receptor Derived Peptides in Immunoregulation and Therapy of Retrovirally Induced Immunosuppression, Ronald Watson and John Marchalonis, in press, Critical Reviews of Immunology.

T Cell Receptor Peptides and Methods for Preventing the Progression to AIDS in an Animal Model, U.S. patent 5,911,990, June, 1999.

T cell Receptor V beta CDR1 Peptide Administration Moderates Immune Dysfunction and Cytokine Dysregulation Induced by Murine Retrovirus Infection, Ronald Watson and John Marchalonis, Journal of Immunology, 155: 2282-2291, 1995.

Electronic:
Good starting point at NIH Division of AIDS.

Joint United Nations Program on HIV/AIDS (UNAIDS).

International AIDS Vaccine Initiative

Check out our multiprotein credits.